At 10.1% CAGR, Nuclear Medicine Market Size to Surpass USD 15.8 Million by 2025
Pune, Maharashtra, India, February 18, 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt Ltd. -: The Nuclear Medicine Market provides a brief analysis of industry size, regional growth, and sales projections for the coming years. The report also highlights key challenges and the latest growth strategies from manufacturers that are part of the competitive spectrum of this business area.
The nuclear medicine market is valued at $ 8.12 million in 2018 and is projected to reach $ 15.8 million by 2025, with an annual growth rate of 10.1% over the forecast period.
Get sample of this report at https://brandessenceresearch.com/requestSample/PostId/406
Top nuclear medicine company
Nuclear Medicine Market Report covers prominent players like
Bracco Imaging SPA Cambridge Isotope Laboratories, Inc. Kardinalgesundheit, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (subsidiary of General Electric Company) IBA Group Isotec, Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (subsidiary of Siemens AG) Taiyo Nippon Sanso Corporation Rotem Industries, Ltd., Inc.
The Nuclear Medicine Market report is segmented on the type, volume of procedure, application, end-user, along with regional as well as country level. Nuclear Medicine Market is divided into Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Nuclear Medicine Research, and others based on type. Based on the volume of procedures, the Nuclear Medicine market is divided into Diagnostic Procedures, Therapeutic Procedures, and others. Depending on the application, the nuclear medicine market is divided into oncology, cardiology, neurology, thyroid, lymphoma, endocrinology, and others. Based on the end user, the nuclear medicine market is divided into diagnostic centers, hospitals, research centers, and others.
Market analysis of nuclear medicine
Nuclear medicine involves the use of radioactive substances in the diagnosis and treatment of various diseases. Nuclear medicine images can aid the doctor in diagnosing many diseases and conditions, such as: B. in analyzing kidney and spleen function, mapping blood flow and heart function, and examining the lungs for airway and blood flow problems. Nuclear medicine uses radioactive materials to diagnose and treat a wide variety of diseases and disorders. It provides unique information about the human body and health. Today, nuclear medicine is expected to be the most sensitive approach to measuring in vivo physiology, biochemistry, and metabolism. The future development of nuclear medicine depends on an infrastructure of physics, mathematics and chemical biology.
The regions covered in this global Nuclear Medicine market report are North America, Europe, Asia Pacific, and the rest of the world. The Nuclear Medicine Market is segmented into United States, Mexico, Canada, United Kingdom, France, Germany, Italy, China, Japan, India, Southeast Asia, GCC, Africa, etc. at the country level.
The Global Nuclear Medicine Market Report Covers Prominent Players Including Bracco Imaging SPA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, and GE Healthcare (subsidiary of General Electric Company) , IBA Group, Isotec, Ntp Radioisotopes (Pty), Ltd., Siemens Healthcare (subsidiary of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, Ltd., Inc. and others.
The increasing prevalence of anxiety and the diagnosis of various diseases are driving the nuclear medicine market.
The increasing prevalence of anxiety and the diagnosis of various diseases are driving the nuclear medicine market. Active pharmaceutical ingredients play an important role in the prevention of arteriosclerosis and its consequences, such as heart attacks, strokes and heart failure. The global prevalence of anxiety disorders varies between 2.5 and 7% depending on the country. Globally, around 284 million people are expected to have an anxiety disorder in 2017, making it the most common mental health or developmental disorder. The increasing prevalence of cancer and cardiovascular disease (CVD) is the key driver of the growth of the nuclear medicine market. Cancer treatment providers should be trained to recognize CVD and perform any necessary interventions concurrently with cancer therapy. However, high costs, isotope scarcity and the risk of traditional / alternative diagnostic methods are hampering the growth of the market. The increasing production of radiopharmaceuticals from cyclotrons, efficient diagnosis and treatment, the expansion of therapeutic applications and the replacement of old / traditional devices are some of the opportunities that are driving the growth of the market.
North America dominates the nuclear medicine market
North America expects the diagnostic radioisotopes segment to grow rapidly in the nuclear medicine market. The volume of PET / CT procedures performed, while cardiology and neurology each account for about 4%. Nuclear cardiology accounts for more than 50% of all nuclear medicine procedures performed in the United States. On the other hand, this means only 14% of those that are carried out in Europe. In the Asia-Pacific region, medical use of ionizing radiation is still a rapidly changing area and exposure to medical radiation has increased, with 39% of Asia-Pacific countries in the health sector. The Asia-Pacific region is growing economically despite the economic decline in the industrialized countries.
Main benefits for market reports –
The global market report has detailed historical and forecast analysis.
The global market research report has in-depth information about the market launch, market summary, global market revenue (revenue USD), market drivers, market restraints, market opportunity, competitive analysis, regional and country level.
The global market report helps identify market opportunities.
The global market report covers a comprehensive analysis of the emerging trends and the competitive landscape.
Nuclear Medicine Market Segmentation –
By type: – Diagnostic nuclear medicine, therapeutic nuclear medicine, research nuclear medicine, other
According to the volume of procedures: – diagnostic procedures, therapeutic procedures, others
By application: – Oncology, cardiology, neurology, thyroid, lymphoma, endocrinology, other
By end user: – Diagnostic Centers, Hospitals, Research Centers, Others
According to regional and country analysis
North America, USA, Mexico, Chile, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, Middle East and Africa, GCC, Africa, rest of the Middle East and Africa
contents
Chapter 1 – Reporting methodology
1.1. Search process
1.2. Primary research
1.3. Desk research
1.4. Market size estimates
1.5. Data triangulation
1.6. Forecast model
1.7. USPs of the report
1.8. Report description
Chapter 2 – Overview of the Global Nuclear Medicine Market: Qualitative Analysis
2.1. Launch
2.2. Summary
2.3. Global Nuclear Medicine Market Classification
2.4. Market leader
2.5. Market restrictions
2.6. Market opportunity
2.7. Nuclear Medicine Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market attractiveness analysis
Chapter 3 – Global Nuclear Medicine Market Review: Quantitative Analysis
Chapter 4 – Global Nuclear Medicine Market Analysis: Segmentation By Type
Chapter 5 – Global Nuclear Medicine Market Analysis: Segmentation By Application
Continuation….
Full report details at https://brandessenceresearch.com/healthcare/nuclear-medicine-market-latest
About us: Brandessence Market Research and Consulting Pvt. GmbH.
Brandessence Market Research publishes market research reports and business intelligence prepared by highly trained and experienced industry analysts. Our research reports are available in a wide variety of industries including aerospace, food and beverage, healthcare, ICT, construction, chemistry and many more. Brand Essence market research report is best suited for Executives, Business Development Managers, Marketing Managers, Consultants, CEOs, CIOs, COOs and Directors, Governments, Agencies, Organizations, and PhD students. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us on: +44 2038074155 or send an email to [email protected]
Website: https://brandessenceresearch.com/
Article: https://businessstatsnews.com
Related report:
This content was created by Brandessence Market Research and Consulting Pvt Ltd. released. WiredRelease’s news department was not involved in the creation of this content. For inquiries about the press release service, please contact us at [email protected].
Comments are closed.